ANA tests can absolutely flip from positive to negative, and it happens more often than most people expect. In one study that tracked repeated ANA tests, about 9% of retests shifted from a previously positive result to a negative one.1PubMed Central. Frequency of Repeating Antinuclear Antibody Testing: When Less Is More The reasons range from biology to lab technique, and understanding why a result can change saves a lot of unnecessary anxiety.
How Often ANA Results Actually Change on Retest
When researchers looked at 479 repeated ANA tests, they found that about two-thirds of results stayed the same. Of the ones that did change, the most common shift was from positive to negative, not the other way around. Only about 5% of retests went from negative to positive, while 9% went from positive to negative.1PubMed Central. Frequency of Repeating Antinuclear Antibody Testing: When Less Is More In other words, a low positive result disappearing on a second draw is roughly twice as common as a negative result turning positive.
The strength of the initial result matters enormously here. The tests that flipped were almost always weak or mildly positive, meaning titers of 1:40 or 1:80 to 1:160. Tests with moderate positivity (1:320 to 1:640) barely changed at all, with only about 1.7% shifting, and strongly positive tests (1:1280 or above) never changed in the study.1PubMed Central. Frequency of Repeating Antinuclear Antibody Testing: When Less Is More If you had a high-titer ANA and it came back negative the second time, that would be genuinely unusual and worth a conversation with your doctor. But a low-titer positive that vanishes on retest? That is the most common pattern of change.
Low-Titer Positives in Healthy People
One reason weak ANA results are so unstable is that many healthy people produce low levels of antinuclear antibodies without having any autoimmune disease. A large cross-sectional study of over 10,800 healthy people in Lebanon found that about 26% tested positive for ANA at a titer of 1:100 or above, though only around 6% had titers exceeding that level.2PubMed. Prevalence of antinuclear antibodies in healthy Lebanese subjects, 2008-2015: a cross-sectional study involving 10,814 subjects A study in Qatar using a different testing method found a much lower prevalence, with only about 0.34% of nearly 3,000 healthy individuals testing positive by ELISA, rising to 0.74% when borderline results were included.3University of the Future: Re-Imagining Research and Higher Education. Prevalence of Antinuclear Antibodies (ANA) among Healthy Individuals with Different Nationalities in Qatar
The massive gap between those two numbers is partly explained by the different tests used, but it also illustrates a key point: a positive ANA does not mean you have lupus or any other autoimmune condition. Many ANA-positive people are perfectly healthy, and their antibody levels can drift above and below the lab’s cutoff from one blood draw to the next. When the underlying level hovers near the threshold, getting a positive result one month and a negative result six months later is almost expected.
Why the Testing Method Itself Creates Inconsistency
There are two main ways labs test for antinuclear antibodies, and they do not always agree with each other. The older method, indirect immunofluorescence (IIF), involves a technician looking at stained cells under a microscope for glowing patterns. The newer method, ELISA, uses an automated plate-based assay to detect antibodies against a panel of specific antigens. When researchers compared the two methods on the same set of over 1,400 blood samples, the overall agreement was only about 70%. Around 6% of samples were positive by ELISA but negative by IIF, and about 8% were positive by IIF but negative by ELISA.4PubMed Central. Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases
This means that if your first ANA was run by immunofluorescence and the second by ELISA (or vice versa), the change in result might have nothing to do with your biology. It could simply reflect what the test can detect. Some patterns, particularly less common ones like nucleolar or peripheral staining, tend to show up on immunofluorescence but get missed by standard ELISA panels because those panels do not include the relevant antigens.5Journal of Contemporary Clinical Practice. Diagnostic Accuracy of ELISA versus Indirect Immunofluorescence in Detecting Anti-Nuclear Antibodies among Suspected Connective Tissue Disorder Patients The practical takeaway: if you are retesting, find out whether the same method was used both times. A change in method can change the result independent of anything happening in your body.
Even within the same method, the specific kit and the lab processing the sample introduce variability. A study comparing different commercially available IIF kits and computer-aided reading systems found that agreement between them ranged from substantial to almost perfect depending on the kit pairing, but was never 100%.6SpringerLink / PubMed Central. The burden of the variability introduced by the HEp-2 assay kit and the CAD system in ANA indirect immunofluorescence test With immunofluorescence in particular, a human reader has to judge whether the cells are glowing enough to count as positive, which introduces some subjectivity. A borderline sample might be called positive by one technician or lab and negative by another.
Infections That Trigger Temporary ANA Positivity
Viral infections are a well-known cause of transient antinuclear antibody production. When your immune system ramps up to fight certain viruses, it can produce antibodies that cross-react with your own cell proteins through a process called molecular mimicry, where viral components resemble self-antigens closely enough to confuse the immune response.7PubMed Central. Significance of antinuclear antibodies in patients with COVID-19 COVID-19 brought this phenomenon into sharper focus, as many patients developed ANA positivity during or shortly after infection. But the same phenomenon has been documented with hepatitis C, Epstein-Barr virus, and other common infections for decades.
The important distinction is that infection-triggered ANA positivity tends to be temporary. Once the infection clears, the autoantibody levels typically drop back below the threshold. If you happened to have an ANA test drawn while you were fighting off a virus, a positive result at that point followed by a negative result months later is a plausible and relatively benign explanation. This is one of the reasons rheumatologists generally prefer not to test ANA during an active infection, since the result is more likely to be misleading.
Medications That Cause and Then Reverse ANA Positivity
Certain medications can induce the body to produce antinuclear antibodies, sometimes even causing a lupus-like syndrome with joint pain, rashes, and fatigue. This condition, known as drug-induced lupus, is considered reversible. Both the symptoms and the serological markers, including ANA, tend to resolve after the offending medication is stopped.8PubMed Central. Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFĪ± agents
The list of drugs that can trigger this is long and keeps growing. Some of the classic culprits include hydralazine (a blood pressure medication), procainamide (a heart rhythm drug), and isoniazid (a tuberculosis treatment). More recently, biologic therapies used for conditions like rheumatoid arthritis and psoriasis have been recognized as triggers. In one case report, a patient who developed kidney inflammation and positive ANA while taking etanercept (a TNF-blocking biologic) saw their ANA normalize about seven months after stopping the drug.9Annals of Clinical & Laboratory Science. Spontaneous Resolution of Lupus Nephritis Following Withdrawal of Etanercept
If you tested ANA-positive while on one of these medications and then tested negative after discontinuing it, the drug is the most likely explanation. Your doctor can usually identify whether a medication you are taking is known to trigger autoantibody production.
When Autoimmune Treatment Itself Turns ANA Negative
Here is an outcome that surprises many patients: even people with confirmed autoimmune diseases can see their ANA become negative over time, particularly if they are receiving immunosuppressive therapy. A study comparing lupus patients found that the rate of ANA-negative lupus was significantly higher in patients who had been on treatment with glucocorticoids or immunosuppressants for a prolonged period, around 7.5%, compared to roughly 1.5% in patients tested at the time of their initial diagnosis.10PubMed Central. Antinuclear antibody-negative systemic lupus erythematosus: How many patients and how to identify?
This creates a somewhat counterintuitive situation: a person with real lupus can test ANA-negative after years of treatment. The treatment suppresses the immune activity that was producing the antibodies. This does not mean the disease is gone or cured. It means the serological marker that helped diagnose it is no longer detectable. Rheumatologists know this and typically do not rely on ANA retesting alone to monitor disease activity. Instead, they track more specific markers, symptoms, and organ function.
ANA Patterns and How Stable They Are
When ANA is tested by immunofluorescence, the result includes not just whether it is positive or negative but also the pattern of staining, which can hint at which specific autoantibodies are present. Common patterns include homogeneous (associated with anti-dsDNA antibodies and lupus) and speckled (associated with various extractable nuclear antigens). A study tracking children with lupus and Sjƶgren’s syndrome found that the staining pattern tended to remain fairly consistent over years of follow-up, even when the titer itself fluctuated. Patients with a speckled pattern at diagnosis stayed speckled. Among those with a homogeneous pattern, most stayed that way, though a few converted to speckled and four became ANA-negative entirely during follow-up.11PubMed Central. Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjƶgren’s syndrome
This pattern stability has practical implications. If you test positive with a homogeneous pattern and then test negative, the antibodies producing that pattern may have simply dipped below the detection threshold rather than disappeared completely. But if your pattern changed dramatically between tests, that is worth discussing with your doctor, as it could reflect a change in the type of autoantibodies your body is producing.
Age and Hormones as Moving Targets
ANA positivity is not a fixed trait throughout life. Hormonal shifts appear to influence autoantibody production, which means ANA status can change as a person ages. One study tracking children with chronic musculoskeletal pain found that ANA positivity increased from about 13% at baseline to nearly 45% across puberty. This increase was independent of symptoms, suggesting that the hormonal changes of puberty themselves were driving autoantibody production rather than any worsening disease.12PubMed Central. Antinuclear antibodies in children: clinical signification and diagnosis utility
In adults, ANA positivity becomes more common with advancing age, particularly in women after menopause. The interplay of estrogen, immune regulation, and aging creates a shifting baseline. A teenager who tests ANA-positive during puberty might test negative a few years later when hormonal levels stabilize. An older adult who was always ANA-negative might test positive for the first time in their sixties without developing any autoimmune symptoms. These shifts are real biological changes, not lab errors, but they do not necessarily signal disease.
When a Flip in Results Should Prompt Further Investigation
Not all ANA fluctuations are benign. A few scenarios warrant closer medical attention rather than a shrug. If your ANA was strongly positive (titers at 1:320 or above) and then turns negative without any clear reason like starting an immunosuppressive medication, that is unusual enough to investigate. As the retesting data showed, high-titer results almost never flip on their own.1PubMed Central. Frequency of Repeating Antinuclear Antibody Testing: When Less Is More
If you have active symptoms consistent with an autoimmune condition, like joint pain, rashes, unexplained fevers, or kidney problems, a negative ANA does not rule out disease. Some patients with confirmed lupus are ANA-negative, and other autoantibodies like anti-dsDNA or anti-ENA can be present even when the ANA screen is negative. In one analysis of patients who were ANA-negative but anti-dsDNA positive, about 21% also tested positive for anti-ENA antibodies.13Arthritis & Rheumatology. Identification of Patients with ANA Negative and Double Stranded DNA Positive: What Is the Significance in Daily Rheumatology Practise ANA is a screening test, not the final word.
If you are being monitored for a known autoimmune condition and your ANA disappears, your rheumatologist will likely interpret that in the context of your overall clinical picture and specific antibody profile, not as a sign that you are cured. A single lab value in isolation rarely tells the whole story.
Should You Retest, and How Often?
Many physicians order repeat ANA tests without a clear clinical reason, often just to “check again.” The evidence suggests this is rarely helpful. Since most retests come back unchanged, and the ones that do change are almost always low-titer results drifting around the cutoff, repeating the test in someone with a stable clinical picture generates more confusion than clarity. The study examining 479 repeated tests found that most were ordered more than a year apart, and the majority of seroconversions involved clinically insignificant low-titer results.1PubMed Central. Frequency of Repeating Antinuclear Antibody Testing: When Less Is More
There are situations where retesting makes sense: if the first result might have been confounded by an acute infection, if a medication that could induce ANA has been started or stopped, or if new symptoms have emerged that change the clinical question being asked. But retesting a stable, asymptomatic patient simply because the first ANA was mildly positive is unlikely to yield useful information and may lead to unnecessary worry or further testing.
ANA and Pregnancy
ANA testing comes up frequently in the context of recurrent pregnancy loss, where it is sometimes ordered as part of a workup for immune-related causes. A study of women with recurrent miscarriage found that about 35% tested ANA-positive at a low cutoff of 1:40, but this dropped to around 11% at 1:80 and about 3% at 1:160 or above. The subsequent live birth rates were essentially the same between ANA-positive and ANA-negative groups regardless of which cutoff was used.14Oxford Academic. Association between antinuclear antibodies and pregnancy prognosis in recurrent pregnancy loss patients A low-positive ANA during a pregnancy workup that later turns negative does not appear to carry meaningful prognostic information for future pregnancies based on this data.
Pregnancy itself involves significant immune modulation, since the body must tolerate a genetically distinct fetus. Autoantibody levels can fluctuate during and after pregnancy for reasons that have nothing to do with autoimmune disease. If you were tested during pregnancy or shortly postpartum and then tested again months later with a different result, the hormonal and immune shifts of pregnancy could account for the change.